comparemela.com
Home
Live Updates
Arkets Bgne Us07725l1026 - Breaking News
Pages:
Latest Breaking News On - Arkets bgne us07725l1026 - Page 1 : comparemela.com
BRUKINSA® Approved in Canada for the Treatment of Chronic Lymphocytic Leukemia
BeiGene’s BTKi is approved in more than 65 markets globally . | May 30, 2023
United states
South korea
United kingdom
Great britain
Mehrdad mobasher
Christine chen
Raymond vles
European union
Beigene ltd
Exchange commission
Princess margaret cancer centre
Health canada
Chief medical officer
Clinician investigator
Princess margaret cancer
American society
BeiGene Receives New Approvals for BRUKINSA® (zanubrutinib) in China
BRUKINSA is approved for first-line treatment for CLL/SLL and WM in China and has multiple approved indications in more than 65 markets worldwide . | May 6, 2023
United states
United kingdom
Ma jun
Lai wang
Exchange commission
Harbin institute of hematology oncology
Supervisor of supervisory committee
American cancer society
End results program
Chinese society of clinical oncology
China national medical products administration
National cancer institute
Lymphoma research foundation
Supplemental new drug applications
Supplemental applications
Gene beigene receives new approvals
vimarsana © 2020. All Rights Reserved.